Dapagliflozin is an SGLT2 inhibitor prescription tablet used primarily to manage type 2 diabetes by removing excess sugar via urine. It is also prescribed to reduce the risk of hospitalization in heart failure patients and to slow the progression of chronic kidney disease (CKD). It may also aid in weight loss and blood pressure reduction.
Kuala Lumpur, Malaysia, Malaysia, 1